These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
129 related articles for article (PubMed ID: 10816681)
41. Favorable mortality profile of naltrexone implants for opiate addiction. Reece AS J Addict Dis; 2010 Jan; 29(1):30-50. PubMed ID: 20390697 [TBL] [Abstract][Full Text] [Related]
42. Regarding naltrexone for probationers and parolees. Stancliff S J Subst Abuse Treat; 2007 Mar; 32(2):217-8; author reply 218-9. PubMed ID: 17306730 [No Abstract] [Full Text] [Related]
43. Naltrexone in the treatment of opioid dependence. George S; Ekhtiari H Br J Hosp Med (Lond); 2010 Oct; 71(10):568-70. PubMed ID: 21085073 [No Abstract] [Full Text] [Related]
45. The pruritus of cholestasis is relieved by an opiate antagonist: is this pruritus a centrally mediated phenomenon? Heathcote J Hepatology; 1996 May; 23(5):1280-2. PubMed ID: 8621166 [No Abstract] [Full Text] [Related]
46. Naloxone and Maintenance Naltrexone as Novel and Effective Therapies for Immunotherapy-Induced Pruritus: A Case Report and Brief Literature Review. Singh R; Patel P; Thakker M; Sharma P; Barnes M; Montana S J Oncol Pract; 2019 Jun; 15(6):347-348. PubMed ID: 31107626 [No Abstract] [Full Text] [Related]
47. Opiate receptor antagonists for delusions of parasitosis. Botschev C; Müller N Biol Psychiatry; 1991 Sep; 30(5):530-1. PubMed ID: 1657224 [No Abstract] [Full Text] [Related]
48. Methylnaltrexone: new drug. Opiate-induced constipation: barely more effective than placebo. Prescrire Int; 2009 Aug; 18(102):158. PubMed ID: 19743572 [No Abstract] [Full Text] [Related]
49. [Naltrexone--high expectations to low dosages]. Raknes G; Giverhaug T Tidsskr Nor Laegeforen; 2011 May; 131(8):844-6. PubMed ID: 21556092 [No Abstract] [Full Text] [Related]
50. Decision to recommend drug to cut drink dependence proves controversial. Wise J BMJ; 2014 Oct; 349():g6054. PubMed ID: 25287870 [No Abstract] [Full Text] [Related]
51. Use of narcotic antagonists to modify stereotypic self-licking, self-chewing, and scratching behavior in dogs. Dodman NH; Shuster L; White SD; Court MH; Parker D; Dixon R J Am Vet Med Assoc; 1988 Oct; 193(7):815-9. PubMed ID: 3192459 [TBL] [Abstract][Full Text] [Related]
52. Naltrexone treatment of dementia with severe self-injurious behaviors: a single case study. Vance HB; Kauffmann C; Pumariega AJ; Del Mundo A Psychiatry; 2000; 63(3):288-99. PubMed ID: 11125673 [TBL] [Abstract][Full Text] [Related]
53. Naltrexone implants can completely prevent early (1-month) relapse after opiate detoxification: a pilot study of two cohorts totalling 101 patients with a note on naltrexone blood levels. Foster J; Brewer C; Steele T Addict Biol; 2003 Jun; 8(2):211-7. PubMed ID: 12850780 [TBL] [Abstract][Full Text] [Related]
54. Active surveillance of adverse events associated with naltrexone in New South Wales. Thackway SV; Ward PL; Taylor LK Med J Aust; 1999 Nov; 171(9):499-500. PubMed ID: 10615347 [No Abstract] [Full Text] [Related]
55. Naltrexone in the treatment of alcoholism. Weinrieb RM; O'Brien CP Annu Rev Med; 1997; 48():477-87. PubMed ID: 9046978 [TBL] [Abstract][Full Text] [Related]
56. Strategies to maximize the efficacy of naltrexone for alcohol dependence. O'Malley SS NIDA Res Monogr; 1995; 150():53-64. PubMed ID: 8742772 [No Abstract] [Full Text] [Related]
57. Naltrexone-Associated Acute Pancreatitis. Verma R Prim Care Companion CNS Disord; 2016 Nov; 18(6):. PubMed ID: 27922226 [No Abstract] [Full Text] [Related]
58. Naltrexone in patients with bipolar disorder and alcohol dependence. Brown ES; Beard L; Dobbs L; Rush AJ Depress Anxiety; 2006; 23(8):492-5. PubMed ID: 16841344 [TBL] [Abstract][Full Text] [Related]
59. Management of the pruritus of cholestasis: potential role of opiate antagonists. Bergasa NV; Jones EA Am J Gastroenterol; 1991 Oct; 86(10):1404-12. PubMed ID: 1928030 [No Abstract] [Full Text] [Related]
60. Naltrexone (vivitrol)--a once-monthly injection for alcoholism. Med Lett Drugs Ther; 2006 Jul; 48(1240):63-4. PubMed ID: 16874283 [No Abstract] [Full Text] [Related] [Previous] [Next] [New Search]